MAP2 and Huntington disease: Also, dendritic (MAP2+) and axonal (Tau+) lengths in HD MSNs were shorter than control neurons, however, CHIR99021 treatment significantly increased these dimensions in HD patient MSNs (Fig. 1h–j), further supporting a role for CHIR99021 in neuronal survival.